Identification of the Molecular Targets of MLL Translocation-Based Childhood Leukemia |
Stowers Institute for Medical Research / Ali Shilatifard |
Innovation Grants |
2010 |
Missouri |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Identification of New Therapeutic Targets in Pediatric Acute Lymphoblastic Leukemia Through Mosaic Trisomy and Aneuploidy-Based Synthetic Lethality Screens |
Dana-Farber Cancer Institute / David Pellman |
Innovation Grants |
2010 |
Massachusetts |
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research / Andrew Napper |
Innovation Grants |
2010 |
Delaware |
Novel Therapeutic Target in Leukemia Stem Cells |
Cincinnati Children's Hospital Medical Center / James Mulloy |
Innovation Grants |
2010 |
Ohio |
Pathogenesis of T-cell Acute Lymphoblastic Leukemia from Myeloproliferative Disorder |
Duke University / Motonari Kondo |
Innovation Grants |
2010 |
North Carolina |
Understanding the Role of a Novel Hereditary Cancer Gene |
University of Texas Health Science Center at San Antonio / Patricia Dahia |
Innovation Grants |
2010 |
Texas |
A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
Expanding Hope: Innovative Therapy at Shands Children's Hospital |
University of Florida / Amy Smith |
Phase I/II Infrastructure Grants |
2010 |
Florida |
Center for Pediatric T Cell Therapy (CEPET) |
Baylor College of Medicine / Cliona Rooney |
Phase I/II Infrastructure Grants |
2010 |
Texas |